European Journal of Internal Medicine
Volume 18, Issue 2 , Pages 90-100 , March 2007

The syndrome of rhabdomyolysis: Pathophysiology and diagnosis

Received 13 April 2006 ,Accepted 26 September 2006.

References 

  1. Knochel JP. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol. 1993;5:725–731
  2. Poels PJE, Gabreels FJM. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg. 1993;95:175–192
  3. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996;49:314–326
  4. Larbi EB. Drug induced rhabdomyolysis: case report. East Afr Med J. 1997;74:829–831
  5. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11:1553–1556
  6. Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem. 2000;37:581–587
  7. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intens Care Med. 2001;27:803–811
  8. Holt S, Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol. 2000;8:72–76
  9. Allison RC, Bedsole DL. The other medical causes of rhabdomyolysis. Am J Med Sci. 2003;326:79–88
  10. Lindner A, Zierz S. Rhabdomyolysis and myoglobinuria. Nervenarzt. 2003;74:505–515
  11. Polderman KH. Acute renal failure and rhabdomyolysis. Int J Artif Organs. 2004;27:1030–1033
  12. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore). 2005;84:377–385
  13. Billis AG, Kastanakis S, Giamarellou H, Daikos GK. Acute renal failure after a meal of quail. Lancet. 1971;2:702
  14. Bywaters EGL, Beall D. Crush injuries with impairment of renal function. BMJ. 1941;1:427–432
  15. Guerini D, Coletto L, Carafoli E. Exporting calcium from cells. Cell Calcium. 2005;38:281–289
  16. Carafoli E. Intracellular calcium homeostasis. Ánn Rev Biochem. 1987;56:395–433
  17. Green HJ. Cation pumps in skeletal muscle: potential role in muscle fatigue. Acta Physiol Scand. 1998;162:201–213
  18. Moller JV, Nissen P, Sorensen TL, le Maire M. Transport mechanism of the sarcoplasmic reticulum Ca2+-ATPase pump. Curr Opin Struct Biol. 2005;15:387–393
  19. Clausen T. Na+–K+pump regulation and skeletal muscle contractility. Physiol Rev. 2003;83:1269–1324
  20. Knochel JP. Neuromuscular manifestations of electrolyte disorders. Am J Med. 1982;72:521–535
  21. Pfeiffer DR, Gunter TE, Eliseev R, Broekemeier KM, Gunter KK. Release of Ca2+ from mitochondria via the saturable mechanisms and the permeability transition. IUBMB Life. 2001;52:205–212
  22. Campanella M, Pinton P, Rizzuto R. Mitochondrial Ca2+ homeostasis in health and disease. Biol Res. 2004;37:653–660
  23. Turrens JF, Beconi M, Barilla J, Chavez UB, McCord JM. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun. 1991;12–13:681–689
  24. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve. 2002;25:332–347
  25. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol. 2005;205:1–16
  26. Lopez JR, Rojas B, Gonzalez MA, Terzic A. Myoplasmic Ca++ concentration during exertional rhabdomyolysis. Lancet. 1995;345:424–425
  27. Wrogemann K, Pena SDJ. Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet. 1976;1:672–674
  28. Rizzuto R, Pinton P, Ferrari D, Chami M, Szabadkai G, Magalhaes PJ, et al. Calcium and apoptosis: facts and hypotheses. Oncogene. 2003;22:8619–8627
  29. Gordon N. Glycogenosis type V or McArdle's disease. Dev Med Child Neurol. 2003;45:640–644
  30. Dimaur S, Andreu AL, Bruno C, Hadjigeorgiou GM. Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med. 2002;2:189–196
  31. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine. 1982;61:141–153
  32. Prendergast BD, George CF. Drug-induced rhabdomyolysis — mechanisms and management. Postgrad Med J. 1993;69:333–336
  33. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32:140–163
  34. Blanco JR, Zabalza M, Salcedo J, San Román J. Rhabdomyolysis as a result of Streptococcus pneumoniae: report of a case and review. Clin Microbiol Infect. 2003;9:944–948
  35. Singh D, Chander V, Chopra K. Rhabdomyolysis. Methods Find Exp Clin Pharmacol. 2005;27:39–48
  36. Ali SZ, Taguchi A, Rosenberg H. Malignant hyperthermia. Best Pract Res Clin Anaesthesiol. 2003;17:519–533
  37. Wedel DJ. Malignant hyperthermia and neuromuscular disease. Neuromuscul Disord. 1992;2:157–164
  38. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289:1681–1690
  39. Guis S, Mattei JP, Liote F. Drug-induced and toxic myopathies. Best Pract Res Clin Rheumatol. 2003;17:877–907
  40. Allen DG. Skeletal muscle function: role of ionic changes in fatigue, damage and disease. Clin Exp Pharmacol Physiol. 2004;31:485–493
  41. Nohl H, Gille L, Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochem Pharmacol. 2005;69:719–723
  42. Moopanar TR, Allen DG. Reactive oxygen species reduce myofibrillar Ca2+ sensitivity in fatiguing mouse skeletal muscle at 37 degrees C. J Physiol. 2005;564:189–199
  43. Smith MA, Reid MB. Redox modulation of contractile function in respiratory and limb skeletal muscle. Respir Physiol Neurobiol. Apr 28 2006;151(2–3):229–241
  44. Vernon LP, Bell JD. Membrane structure, toxins and phospholipase A2 activity. Pharmacol Ther. 1992;54:269–295
  45. Nigam S, Schewe T. Phospholipase A(2)s and lipid peroxidation. Biochim Biophys Acta. 2000;1488:167–181
  46. Gommans IM, Vlak MH, de Haan A, van Engelen BG. Calcium regulation and muscle disease. J Muscle Res Cell Motil. 2002;23:59–63
  47. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love–hate triangle. Am J Physiol Cell Physiol. 2004;287:C817–C833
  48. Cadenas E. Biochemistry of oxygen toxicity. Ann Rev Biochem. 1989;58:79–110
  49. Cooper CE, Vollaard NB, Choueiri T, Wilson MT. Exercise, free radicals and oxidative stress. Biochem Soc Trans. 2002;30:280–285
  50. Brookes PS. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radic Biol Med. 2005;38:12–23
  51. Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol. 2005;149:240–260
  52. DiMauro S, Tanji K, Bonilla E, Pallotti F, Schon EA. Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects. Muscle Nerve. 2002;26:597–607
  53. Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol. 2005;37:2478–2503
  54. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal. 2005;7:1302–1314
  55. Scheffler IE. A century of mitochondrial research: achievements and perspectives. Mitochondrion. 2001;1:3–31
  56. Nakahara K, Yada T, Kuriyama M, Osame M. Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors. Biochem Biophys Res Commun. 1994;202:1579–1585
  57. Le Bras M, Clement MV, Pervaiz S, Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol. 2005;20:205–219
  58. Duchen MR. Mitochondria and Ca2+ in cell physiology and pathophysiology. Cell Calcium. 2000;28:339–348
  59. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res. 2004;567:1–61
  60. Juranek I, Bezek S. Controversy of free radical hypothesis: reactive oxygen species — cause or consequence of tissue injury?. Gen Physiol Biophys. 2005;24:263–278
  61. Kantrow SP, Piantadosi CA. Release of cytochrome c from liver mitochondria during permeability transition. Biochem Biophys Res Commun. 1997;232:669–671
  62. Zamzami N, Hirsch T, Dallaporta B, Petit PX, Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J Bioenerg Biomembr. 1997;29:185–193
  63. Wardle EN. Cellular oxidative processes in relation to renal disease. Am J Nephrol. 2005;25:13–22
  64. Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit Care Clin. 2004;20:171–192
  65. Criddle LM. Rhabdomyolysis: pathophysiology, recognition and management. Crit Care Nurse. 2003;23:14–22
  66. Koffler A, Friedler RM, Massry SG. Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med. 1976;85:23–28
  67. Knochel JP. Pigment nephropathy. In:  Greenberg A editors. Primer on kidney diseases. Boston: Academic Press; 1998;p. 273–276
  68. Köppel C. Clinical features, pathogenesis and management of drug-induced rhabdomyolysis. Med Toxicol Adverse Drug Exp. 1989;4:108–126
  69. Rusell TA. Acute renal failure related to rhabdomyolysis: pathophysiology, diagnosis and collaborative management. Nephrol Nurs J. 2000;27:567–575
  70. Schlattner U, Tokarska-Schlattner M, Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta. 2006;1762:164–180
  71. Kasper CE, Talbot LA, Gaines JM. Skeletal muscle damage and recovery. AACN Clin Issues. 2002;13:237–247
  72. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 1988;148:1553–1557
  73. Berner YN, Shike M. Consequences of phosphate imbalance. Annu Rev Nutr. 1988;8:121–148
  74. Meneghini LF, Oster JR, Camacho JR, Gkonos PJ, Roos BA. Hypercalcemia in association with acute renal failure and rhabdomyolysis. case report and literature review. Miner Electrolyte Metab. 1993;19:1–16
  75. Llach F, Felsenfeld AJ, Haussler MR. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol.. N Engl J Med. 1981;305:117–123

PII: S0953-6205(06)00302-5

doi: 10.1016/j.ejim.2006.09.020

European Journal of Internal Medicine
Volume 18, Issue 2 , Pages 90-100 , March 2007

Article Tools

* Image Usage & Resolution